Stock Market News3 months Pharma Stock Roundup: AZN, BAYRY’s Earnings, ABBV’s Pipeline Setback Zacks
AZN and BAYRY announce Q3 results. ABBV’s studies on schizophrenia candidate, emraclidine, fail to meet goal.
XAZN and BAYRY announce Q3 results. ABBV’s studies on schizophrenia candidate, emraclidine, fail to meet goal.
X